{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:35:31Z","timestamp":1793414131166,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":3687,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1111\/j.1538-7836.2012.04919.x","type":"journal-article","created":{"date-parts":[[2012,9,10]],"date-time":"2012-09-10T12:46:35Z","timestamp":1347281195000},"page":"2277-2286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":177,"title":["Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study"],"prefix":"10.1016","volume":"10","author":[{"given":"S.","family":"SWEETLAND","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"BERAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"BALKWILL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.S.","family":"BENSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"CANONICO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"GREEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.K.","family":"REEVES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2141.2010.08128.x","article-title":"Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology","volume":"149","author":"Ohira","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(96)07114-0","article-title":"Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens","volume":"348","author":"Jick","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0020","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(96)07113-9","article-title":"Risk of venous thromboembolism in users of hormone replacement therapy","volume":"348","author":"Daly","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0025","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(96)07308-4","article-title":"Prospective study of exogenous hormones and risk of pulmonary embolism in women","volume":"348","author":"Grodstein","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0030","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/eurheartj\/ehn299","article-title":"Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta\u2010analysis","volume":"29","author":"Sare","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0035","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial","volume":"305","author":"LaCroix","year":"2011","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0040","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1538-7836.2005.01268.x","article-title":"Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case\u2010control study","volume":"3","author":"Douketis","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0045","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.292.13.1581","article-title":"Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis","volume":"292","author":"Smith","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0050","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jama.299.9.1036","article-title":"Health risks and benefits 3\u2003years after stopping randomized treatment with estrogen and progestin","volume":"299","author":"Heiss","year":"2008","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0055","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archinte.166.7.772","article-title":"Venous thrombosis and conjugated equine estrogen in women without a uterus","volume":"166","author":"Curb","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0060","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0065","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study","volume":"30","author":"Canonico","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0070","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1538-7836.2010.03839.x","article-title":"Hormone replacement therapy and the risk of venous thromboembolism: a population\u2010based study","volume":"8","author":"Renoux","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0075","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/bmj.314.7083.796","article-title":"Hormone replacement therapy and risk of venous thromboembolism: population based case\u2010control study","volume":"314","author":"Perez Gutthann","year":"1997","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/oxfordjournals.aje.a009461","article-title":"Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population\u2010based study in southern Europe","volume":"147","author":"Varas\u2010Lorenzo","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0085","first-page":"73","article-title":"The Million Women Study Collaborative Group","volume":"1","year":"1999","journal-title":"Breast Cancer Res"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0090","first-page":"72","article-title":"The Scottish Record Linkage System","volume":"51","author":"Kendrick","year":"1993","journal-title":"Health Bull"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0095","unstructured":"The NHS Information Centre. HESonline \u2013 Hospital Episode Statistics. http:\/\/www.hesonline.nhs.uk\/. Accessed 7 December 2011."},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0100","series-title":"International Statistical Classification of Diseases and Related Health Problems \u2013 Tenth revision","year":"1992"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0105","series-title":"Tabular List of the Classification of Surgical Operations and Procedures","year":"1990"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone\u2010replacement therapy in the Million Women Study","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0115","doi-asserted-by":"crossref","first-page":"b4583","DOI":"10.1136\/bmj.b4583","article-title":"Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study","volume":"339","author":"Sweetland","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0125","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00228-007-0320-6","article-title":"Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005","volume":"63","author":"Watson","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0130","series-title":"Health and Deprivation: Inequality and the North","author":"Townsend","year":"1988"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0135","series-title":"British National Formulary","author":"Mehta","year":"1999"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0140","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S1470-2045(06)70911-1","article-title":"Hormonal therapy for menopause and breast\u2010cancer risk by histological type: a cohort study and meta\u2010analysis","volume":"7","author":"Reeves","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0145","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","article-title":"Ovarian cancer and hormone replacement therapy in the Million Women Study","volume":"369","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0150","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone\u2010replacement therapy in the Million Women Study","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0155","series-title":"Drug Safety Update","year":"2007"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Noncardiovascular disease outcomes during 6.8\u2003years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow\u2010up (HERS II)","volume":"288","author":"Hulley","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.39266.425069.AD","article-title":"Main morbidities recorded in the women\u2019s international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women","volume":"335","author":"Vickers","year":"2007","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0170","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0175","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MOH.0b013e32833c07bc","article-title":"Risk of venous thrombosis with oral vs. transdermal estrogen therapy among postmenopausal women","volume":"17","author":"Olie","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0180","doi-asserted-by":"crossref","first-page":"a386","DOI":"10.1136\/bmj.a386","article-title":"Gallbladder disease and use of transdermal vs. oral hormone replacement therapy in postmenopausal women: prospective cohort study","volume":"337","author":"Liu","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0185","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/aje\/kwi223","article-title":"Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women\u2019s Health Initiative clinical trial","volume":"162","author":"Prentice","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0190","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen\u2010replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0195","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1055\/s-0037-1614363","article-title":"Hormone replacement therapy with estradiol and risk of venous thromboembolism\u2010\u2010a population\u2010based case\u2010control study","volume":"82","author":"Hoibraaten","year":"1999","journal-title":"Thromb Haemost"},{"issue":"Suppl 3","key":"10.1111\/j.1538-7836.2012.04919.x_bb0200","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S0049-3848(11)70008-1","article-title":"Postmenopausal hormone therapy and venous thromboembolism","volume":"127","author":"Olie","year":"2011","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0205","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1538-7836.2006.01933.x","article-title":"Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study","volume":"4","author":"Canonico","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0210","series-title":"An Assessment of SMR01 and Associated Data 2004\u20102006","year":"2007"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2257.2004.00660.x","article-title":"Procedures for the outpatient management of patients with deep venous thrombosis","volume":"27","author":"Winter","year":"2005","journal-title":"Clin Lab Haematol"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0220","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/emj.2004.020610","article-title":"How is deep vein thrombosis diagnosed and managed in UK and Australian emergency departments?","volume":"22","author":"Sampson","year":"2005","journal-title":"Emerg Med J"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0225","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/13595220152601837","article-title":"Agreement between general practice prescription data and self\u2010reported use of hormone replacement therapy and treatment for various illnesses","volume":"6","author":"Banks","year":"2001","journal-title":"J Epidemiol Biostat"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0230","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jnci\/djq527","article-title":"Breast cancer risk in relation to the interval between menopause and starting hormone therapy","volume":"103","author":"Beral","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1538-7836.2012.04919.x_bb0235","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","article-title":"Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias","volume":"335","author":"MacMahon","year":"1990","journal-title":"Lancet"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2012.04919.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622063930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622063930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2012.04919.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:58:59Z","timestamp":1761533939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622063930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1538783622063930"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04919.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04919.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}